MARKET

MSON

MSON

Misonix
NASDAQ

Real-time Quotes | Nasdaq Last Sale

25.86
-0.35
-1.34%
After Hours: 25.86 0 0.00% 16:00 09/24 EDT
OPEN
25.88
PREV CLOSE
26.21
HIGH
26.04
LOW
25.81
VOLUME
36.42K
TURNOVER
--
52 WEEK HIGH
26.99
52 WEEK LOW
11.04
MARKET CAP
450.22M
P/E (TTM)
-30.7821
1D
5D
1M
3M
1Y
5Y
SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Misonix, Inc. (Nasdaq - MSON)
BALA CYNWYD, PA / ACCESSWIRE / September 24, 2021 / Law office of Brodsky & Smith announces that it is investigating potential claims against the Board of Directors ofMisonix, Inc. ("Misonix" or the "Company") (NASDAQ:MSON) for possible breaches of fiducia...
ACCESSWIRE · 1d ago
BRIEF-Misonix Q4 Loss Per Share $0.26
reuters.com · 09/02 20:05
Misonix Q4 Net Loss $4.473M vs $8.5M In Same Qtr. Last Year, Adj. EBITDA Loss $1.595M, Sales $19.68M Up From $13.71M YoY
Misonix (NASDAQ:MSON) reported $19.68 million in sales this quarter. This is a 43.55 percent increase over sales of $13.71 million the same period last year.
Benzinga · 09/02 20:02
Misonix Q4 Net Loss Narrows, Revenue Surges
MT Newswires · 09/02 16:18
-- Earnings Flash (MSON) MISONIX Posts Q4 Revenue $19.7M
MT Newswires · 09/02 16:13
Harbert Fund Advisors, Inc. Buys Isos Acquisition Corp, Accuray Inc, Nautilus Inc, Sells YETI ...
GuruFocus News · 08/23 04:59
The Daily Biotech Pulse: Sanofi Buys Translate Bio In $3.2B Deal, Lilly's Q2 Earnings Disappoint, Bausch To Spin Off Medical Aesthetics Business
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 2)
Benzinga · 08/03 11:55
Benzinga's Top Ratings Upgrades, Downgrades For August 2, 2021
 
Benzinga · 08/02 14:23
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of MSON. Analyze the recent business situations of Misonix through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 3 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average MSON stock price target is 28.00 with a high estimate of 28.00 and a low estimate of 28.00.
EPS
Institutional Holdings
Institutions: 88
Institutional Holdings: 7.70M
% Owned: 44.22%
Shares Outstanding: 17.41M
TypeInstitutionsShares
Increased
13
255.88K
New
8
108.91K
Decreased
22
430.78K
Sold Out
4
61.42K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
-0.61%
Healthcare Equipment & Supplies
-0.42%
Key Executives
Chairman/Director/Independent Director
Paul LaViolette
President
Allan Staley
Chief Executive Officer/Director
Stavros Vizirgianakis
Chief Financial Officer/Treasurer/Secretary
Joseph Dwyer
Chief Operating Officer
Sharon Klugewicz
Executive Vice President/Director of Sales
Jonathan Waggoner
Senior Vice President/Director of Sales/Director of Marketing
Robert Ludecker
Senior Vice President/Director of Sales
Linwood Staub
Independent Director
Patrick Beyer
Independent Director
Michael Koby
Independent Director
Thomas Patton
No Data
About MSON
Misonix, Inc. (Misonix), is a medical devices company. The Company is engaged in designing, manufacturing and marketing of minimally invasive therapeutic ultrasonic medical devices. Its products include BoneScalpel Surgical System (BoneScalpel), SonicOne Wound Cleansing and Debridement System (SonicOne) and SonaStar Surgical Aspirator (SonaStar). BoneScalpel is used for surgical procedures involving the precise cutting and sculpting of bone while sparing soft tissue. SonaStar is used to emulsify and remove soft and hard tumors, primarily in the neuro and general surgery field. SonicOne offers tissue specific debridement and cleansing of wounds and burns for effective removal of devitalized tissue and fibrin deposits while sparing viable cells. The Company’s products are nexus, BoneScalpel, SonaStar, SonicOne, TheraSkin and Therion.

Webull offers kinds of Misonix Inc stock information, including NASDAQ:MSON real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MSON stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading MSON stock methods without spending real money on the virtual paper trading platform.